Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index; 55 of the 86 sources its claims cite were checked for support.
Abstract
Background: Genome-wide association studies have identified BIN1 within the second most significant susceptibility locus in late-onset Alzheimer’s disease (AD). BIN1 undergoes complex alternative splicing to generate multiple isoforms with diverse functions in multiple cellular processes including endocytosis and membrane remodeling. An increase in BIN1 expression in AD and an interaction between BIN1 and Tau have been reported. However, disparate descriptions of BIN1 expression and localization in the brain previously reported in the literature and the lack of clarity on brain BIN1 isoforms present formidable challenges to our understanding of how genetic variants in BIN1 increase the risk for AD. Methods: In this study, we analyzed BIN1 mRNA and protein levels in human brain samples from individuals with or without AD. In addition, we characterized the BIN1 expression and isoform diversity in human and rodent tissue by immunohistochemistry and immunoblotting using a panel of BIN1 antibodies. Results: Here, we report on BIN1 isoform diversity in the human brain and document alterations in the levels of select BIN1 isoforms in individuals with AD. In addition, we report striking BIN1 localization to white matter tracts in rodent and the human brain, and document that the large majority of BIN1 is expressed in mature oligodendrocytes whereas neuronal BIN1 represents a minor fraction. This predominant non-neuronal BIN1 localization contrasts with the strict neuronal expression and presynaptic localization of the BIN1 paralog, Amphiphysin 1. We also observe upregulation of BIN1 at the onset of postnatal myelination in the brain and during differentiation of cultured oligodendrocytes. Finally, we document that the loss of BIN1 significantly correlates with the extent of demyelination in multiple sclerosis lesions. Conclusion: Our study provides new insights into the brain distribution and cellular expression of an important risk factor associated with late-onset AD. We propose that efforts to define how genetic variants in BIN1 elevate the risk for AD would behoove to consider BIN1 function in the context of its main expression in mature oligodendrocytes and the potential for a role of BIN1 in the membrane remodeling that accompanies the process of myelination.
Overview
CoChat Summary
TL;DR
This study shows that Alzheimer’s disease-associated BIN1 is predominantly expressed in mature oligodendrocytes and enriched in white matter tracts in human and rodent brain, with neuronal BIN1 representing a minor fraction. It also reports isoform-specific BIN1 changes in AD gray matter and loss of BIN1 paralleling demyelination in multiple sclerosis lesions.
Key findings
- BIN1 mRNA was expressed at 2,000–30,000 copies per ~20 ng cDNA; the D7-BIN1 isoform accounted for 62 ± 15% (range 23–93%, n = 57) of BIN1, and ~90% of white matter BIN1 corresponded to D7-BIN1 isoforms. White matter contained ~3-fold higher BIN1 levels than gray matter (p < 0.0001 by ANOVA).
- BIN1 immunolabeling was predominantly in mature oligodendrocytes and white matter tracts, with little neuronal labeling; the ~90 kDa BIN1:H isoform was gray-matter restricted, whereas ~65–75 kDa BIN1:L isoforms predominated in gray and white matter. Amphiphysin 1 showed the opposite, neuronal/gray-matter enrichment.
- In AD gray matter, BIN1:H decreased while BIN1:L increased; BIN1:L correlated with the oligodendrocyte marker ASPA (Pearson r = 0.897, p < 0.05) and with GFAP in white matter (Pearson r = 0.936, p < 0.02). BIN1 + Ex7 showed a modest 18% increase in AD, while D7-BIN1 was not significantly associated with AD (p = 0.4).
- BIN1 was upregulated during postnatal myelination and in vitro oligodendrocyte differentiation, was absent from NG2-positive OPCs, microglia, and astrocytes, and its loss correlated with demyelination in multiple sclerosis lesions.
Methods
- Human anterior cingulate autopsy tissue was analyzed by qPCR for BIN1 + Ex7 and D7-BIN1, normalized to EIF4H and RPL32; non-AD donors were 82.3 ± 8.6 years (n = 29) and AD donors 81.7 ± 6.3 years (n = 28), with general linear models including AD status and cell-type markers.
- Immunoblotting, immunohistochemistry, and immunofluorescence used a panel of BIN1 antibodies in human brain samples (Table 1) and rodent tissue; primary rat OPCs were differentiated into mature oligodendrocytes, and rat hippocampal neurons and astrocytes were cultured for comparison.
- BIN1 isoform diversity was assessed by RT-PCR and sequencing of exons 12–18, antibody specificity was tested in transfected HEK293 cells, and multiple sclerosis autopsy tissue was compared with Luxol fast blue staining.
Limitations
- Stated in the paper: the AD association had limited power (0.517); the multiple sclerosis analysis is described as a pilot study; functional BIN1 variants are yet to be identified; precise cellular functions of major brain BIN1 isoforms remain to be established; and a functional BIN1–Tau interaction awaits experimental confirmation.
- Evident from the text: human qPCR was limited to anterior cingulate tissue, the MS lesion analysis was small/pilot, and the study is largely descriptive, with no direct causal or functional experiments testing BIN1’s role in myelination or AD pathogenesis.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
34 Valid · 4 Not valid · 7 Not checked · 139 Own results and interpretations
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“In comparison to Caspr, which becomes concentrated in the paranodal junctions of myelinated axons [49], BIN1 displayed patchy distribution along short segments of interdigitating processes without an apparent concentration in the nodes or the paranodal area (Fig. 4g).”
§ Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts > Results > Predominant white matter localization and oligodendrocyte expression of BIN1 in the human brain
What the sources say
- Could not verifycites [49] Peles E Nativ M Lustig M Grumet M Schilling J Martinez R Plowman GD Schlessinger J Identification of a novel contactin-associated transmembrane receptor with multiple domains implicated in protein-protein interactions EMBO J 1997 16 978 988 10.1093/emboj/16.5.978 9118959 PMC1169698 sourceExperimental — accuracy not yet measured
The citation is attached to the statement that Caspr becomes concentrated at paranodal junctions, not to the citing authors’ BIN1 observation. Our copy’s Discussion describes Caspr as a contactin-associated cell-surface protein, but the passages found for paranodal junctions, myelinated axons, and nodes of Ranvier do not address its localization there; page numbers were not available. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“proteomic identification of BIN1 in human and mouse brain myelin preparations [50].”
§ Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts > Discussion > The significance of BIN1 expression in oligodendrocytes
What the sources say
- Supportedcites [50] Ishii A Dutta R Wark GM Hwang SI Han DK Trapp BD Pfeiffer SE Bansal R Human myelin proteome and comparative analysis with mouse myelin Proc Natl Acad Sci U S A 2009 106 14605 14610 10.1073/pnas.0905936106 19706548 PMC2732873 source
The Results and Discussion list BIN1 in Fig. 3, whose caption identifies its entries as proteins detected by mass spectrometry in both human and mouse myelin fractions. The Methods describe those fractions as preparations from human and mouse brain. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“a significant decrease in BIN1 expression was observed in microarray analysis of multiple sclerosis brain lesions in comparison with control brain samples (GEO DataSet GDS4218) [51].”
§ Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts > Discussion > The significance of BIN1 expression in oligodendrocytes
What the sources say
- Could not verifycites [51] Han MH Lundgren DH Jaiswal S Chao M Graham KL Garris CS Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice J Exp Med 2012 209 1325 1334 10.1084/jem.20101974 22734047 PMC3405500 sourceExperimental — accuracy not yet measured
The Results section describes microarray analysis of MS brain lesions, but the passages found do not report BIN1 expression or a significant decrease relative to controls. Searching the indexed paper for BIN1 and GDS4218 found no supporting passage; Materials and Methods instead lists the paper’s microarray data under GSE38010. No page numbers are available in our copy. (LLM, conf=0.73)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Similar to our findings, no overlap in the cellular expression of BIN1 and Iba1 was observed in the hippocampus of patients with AD [26].”
§ Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts > Discussion > Predominant oligodendrocyte expression of BIN1
What the sources say
- Partly supportedcites [26] Chapuis J Hansmannel F Gistelinck M Mounier A Van Cauwenberghe C Kolen KV Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology Mol Psychiatry 2013 18 1225 1234 10.1038/mp.2013.1 23399914 PMC3807661 sourceExperimental — accuracy not yet measured
The Results section reports that BIN1 was mainly present in neurons and only rarely observed in microglia in AD brain tissue. The Immunohistochemistry section specifies hippocampal sections and use of an Iba1 antibody. These passages support limited BIN1–microglia overlap, but not the categorical claim that no overlap was observed. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Evidence from the analysis of Drosophila Amphiphysin, encoded by the unique Amphiphysin gene (and thought to be a BIN1 ortholog), show that absence of the CLAP domain results in no detectable defects in synaptic vesicle endocytosis in mutant flies [55–57].”
§ Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts > Discussion > BIN1 isoform diversity in the brain
What the sources say
- Not checked — no full text of the sourcecites [55] Leventis PA Chow BM Stewart BA Iyengar B Campos AR Boulianne GL Drosophila Amphiphysin is a post-synaptic protein required for normal locomotion but not endocytosis Traffic 2001 2 839 850 10.1034/j.1600-0854.2001.21113.x 11733051 source
- Partly supportedcites [56] Razzaq A Robinson IM McMahon HT Skepper JN Su Y Zelhof AC Jackson AP Gay NJ O’Kane CJ Amphiphysin is necessary for organization of the excitation-contraction coupling machinery of muscles, but not for synaptic vesicle endocytosis in Drosophila Genes Dev 2001 15 2967 2979 10.1101/gad.207801 11711432 PMC312829 sourceExperimental — accuracy not yet measured
The section ‘Drosophila amphiphysin has no essential role in synaptic vesicle endocytosis’ reports that amphiphysin lacks clathrin-binding motifs and that mutants have little, if any, discernible defect in synaptic transmission. The paper does not identify a CLAP-domain deletion as the cause of that finding: it studied mutants lacking amphiphysin, not flies with a targeted deletion of that domain. Page numbers are unavailable in our copy. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [57] Zelhof AC Bao H Hardy RW Razzaq A Zhang B Doe CQ Drosophila Amphiphysin is implicated in protein localization and membrane morphogenesis but not in synaptic vesicle endocytosis Development 2001 128 5005 5015 11748137 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
103 more claims · 4 with their cited sources checked
Create a free account to see all 184 claims and every source verdict.
- It may state two separate claims as one. 44
- Probably not a substantial claim. 36
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is an important homolog of BIN1, which is highly expressed in oligodendrocytes as well as immune cell types and has been shown to be correlated with tau levels as well as glial fibrillary acidic protein (GFAP) and myelin basic protein (MBP) expression (35).”
From Molecular subtyping of Alzheimer’s disease using RNA sequencing data reveals novel mechanisms and targets (2021) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On the other hand, the level of isoform 9 seems to be correlated with the abundance of astrocyte (GFAP) and microglia (CD45) markers [12].”
From BIN1 protein isoforms are differentially expressed in astrocytes, neurons, and microglia: neuronal and astrocyte BIN1 are implicated in tau pathology (2020) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In addition, high expression of BIN1 has also been reported in mature oligodendrocytes, especially in the white matter of human brain [12].”
From BIN1 protein isoforms are differentially expressed in astrocytes, neurons, and microglia: neuronal and astrocyte BIN1 are implicated in tau pathology (2020) · cites this paper as [12]
In the citing paper
“Unique splicing of Bin1 in microglia and oligodendroglia not seen in neurons or astrocytes has also been suggested [59, 67] and Bin1 has also been identified as a highly abundant microglial protein in a recent microglial proteome [68] although the exact role of Bin1 in homeostatic microglia and in AD pathogenesis remains unclear.”
From Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease (2018) · cites this paper as [67]
In the citing paper
“The expression of the neuronal isoform has been found decreased in AD [36,41].”
From Bin1 and CD2AP polarise the endocytic generation of beta‐amyloid (2017) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts > Methods > Analysis of gene expression
“The primers for BIN1 + Ex7 were: exon 5 sense 5’-CCTGCTGTGGATGGATTACC-3’ and exon 7 antisense 5’-GCTTTCTCAAGCAGCGAGAC-3’.”
§ Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts > Methods > Analysis of gene expression
“D7-BIN1 reactions used the same exon 5 sense primer and a junctional antisense primer, 5’-GCTTTCTCAAGCAGCGAGAC-3’ , corresponding to the last 6 nucleotides of exon 6 and the first 11 nucleotides of exon 8.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts > Conclusions
“BIN1 is the most significant late-onset AD susceptibility locus identified via the genome-wide association studies.”
§ Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts > Abstract > Background
“Genome-wide association studies have identified BIN1 within the second most significant susceptibility locus in late-onset Alzheimer’s disease (AD).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts > Methods > Human autopsy tissue
“Age at death for the cognitively intact, i.e. non-AD donors, was 82.3 ± 8.6 (mean ± SD, n = 29) while AD donors were 81.7 ± 6.3 (mean ± SD, n = 28).”
§ Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts > Methods > Human autopsy tissue
“aAD (n = 29) and non-AD (n = 28) human samples used for qPCR analysis have been previously described”
Citations
Cites
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875 · cited 4×
“Although BIN1 mRNA expression in microglia acutelyisolated from mouse brain was observed in RNA-seq experiments [45], our results show little evidence in support of microglial localization of BIN1 at the protein level in the human or mouse brain.”
InfluentialHarold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Naj, A. C., Jun, G., Beecham, G. W., Wang, L.-S., Vardarajan, B. N., Buros, J., Gallins, P. J., Buxbaum, J. D., Jarvik, G. P., Crane, P. K., et al. (2011) · Nature Genetics · doi:10.1038/ng.801 · Cited by 1,901 · cited 1×
“If the model was expanded to include the AD-associated BIN1 single-nucleotide polymorphism rs7561528 [46], the BIN1 + Ex7 association with synaptophysin was unchanged.”
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857 · cited 1×
“It is notable that BIN1 is ranked in the AlzGene database as the second most statistically significant AD susceptibility gene based on a meta-analysis [25].”
Large-scale analysis of the human and mouse transcriptomes
Su, A. I., Cooke, M. P., Ching, K. A., Hakak, Y., Walker, J. R., Wiltshire, T., Orth, A. P., Vega, R. G., Sapinoso, L. M., Moqrich, A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012025199 · Cited by 1,466 · cited 1×
“This finding is in agreement with the comparison of BIN1 transcript levels between the human white matter and the gray matter reported from independent microarray analyses [50, 52, 53].”
Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease
Seshadri, S. (2010) · JAMA · doi:10.1001/jama.2010.574 · Cited by 1,219
Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship
Nelson, P. T., Braak, H., & Markesbery, W. R. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181919a48 · Cited by 643
Nicot, A.-S., Toussaint, A., Tosch, V., Kretz, C., Wallgren-Pettersson, C., Iwarsson, E., Kingston, H., Garnier, J.-M., Biancalana, V., Oldfors, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2086 · Cited by 434 · cited 1×
“Moreover, the residues encoded by the alternatively spliced exon 7 within the BAR domain promotes BIN1 interaction with dynamin 2 [16, 17].”
Tissue-specific alternative splicing remodels protein-protein interaction networks
Ellis, J. D., Barrios-Rodiles, M., Çolak, R., Irimia, M., Kim, T., Calarco, J. A., Wang, X., Pan, Q., O'Hanlon, D., Kim, P. M., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.05.037 · Cited by 431
David, C., McPherson, P. S., Mundigl, O., & de Camilli, P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.331 · Cited by 409 · cited 1×
“The exclusion of BIN1 exon 11 in brain and inclusion of exon 7 in isoforms 1 and 3 were inferred from the published literature and the RT-PCR and immunoblot results of our study the brain-specific BIN1 homolog [3, 5, 48].”
Cited by
Grubman, A., Chew, G., Ouyang, J. F., Sun, G., Choo, X. Y., McLean, C., Simmons, R. K., Buckberry, S., Vargas-Landin, D. B., Poppe, D., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0539-4 · Cited by 956
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994
“BIN1 is expressed in all neural cell types, and is highly enriched in oligodendrocytes and microglia [476].”
BackgroundBrain cell type–specific enhancer–promoter interactome maps and disease - risk association
Nott, A., Holtman, I. R., Coufal, N. G., Schlachetzki, J. C. M., Yu, M., Hu, R., Han, C. Z., Pena, M., Xiao, J., Wu, Y., et al. (2019) · Science · doi:10.1126/science.aay0793 · Cited by 699
Rangaraju, S., Dammer, E. B., Raza, S. A., Rathakrishnan, P., Xiao, H., Gao, T., Duong, D. M., Pennington, M. W., Lah, J. J., Seyfried, N. T., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0254-8 · Cited by 430
“not seen in neurons or astrocytes has also been suggested [59, 67] and Bin1 has also been identified as a highly abundant microglial protein in a recent microglial proteome [68] although the exact role of Bin1 in homeostatic microglia and in AD pathogenesis remains unclear.”
BackgroundNeff, R. A., Wang, M., Vatansever, S., Guo, L., Ming, C., Wang, Q., Wang, E., Horgusluoglu-Moloch, E., Song, W.-M., Li, A., et al. (2021) · Science Advances · doi:10.1126/sciadv.abb5398 · Cited by 324
Metadata
- Authors
- De Rossi, P., Buggia-Prévot, V., Clayton, B. L. L., Vasquez, J. B., van Sanford, C., Andrew, R. J., Lesnick, R., Botté, A., Deyts, C., Salem, S., Rao, E., Rice, R. C., Parent, A., Kar, S., Popko, B., Pytel, P., Estus, S., & Thinakaran, G.
- Affiliations
- University of Chicago (US)
- University of Kentucky (US)
- University of Alberta (CA)
- Corresponding author
- Thinakaran, Gopal
- ORCID
- Venue
- Molecular Neurodegeneration
- Published
- 2016-08-03
- Volume
- 11
- Issue
- 1
- Pages
- 59-59
- ISSN
- 1750-1326 (ISSN-L)
- PMC
- PMC4973113
- OpenAlex
- W2491615326
- Semantic Scholar
- 3af2389ee7c3d8f6dc081782b2c809620fcf0ad7
- Cited by
- 151
- References
- 71
- Citations by year
- 2026: 15 · 2025: 18 · 2024: 15 · 2023: 17 · 2022: 26 · 2021: 13 · 2020: 16 · 2019: 13 · 2018: 11 · 2017: 6 · 2016: 1
- FWCI
- 7.06
- Type
- journal article
- Language
- en
- Update notices
- correction (2023-10-02)
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Molecular Neurodegeneration (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UKnowledge (University of Kentucky) (submittedVersion, cc-by)
- PubMed Central (submittedVersion, cc-by)
- Funders
- Cure Alzheimer's Fund
- National Multiple Sclerosis Society and Illinois Department of Public Health Multiple Sclerosis Research Fund Grant (63285002D)
- BrightFocus Foundation
- National Institute on Aging (AG019070, AG045775, P30-AG028383)
- National Institutes of Health (NS034939, S10OD010649)
- Illinois Department of Public Health
- National Center for Advancing Translational Sciences (UL1TR000117, UL1 TR 000430-09)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- BIN1, Alzheimer's disease, late-onset Alzheimer's disease, oligodendrocytes, white matter tracts, alternative splicing, demyelination, multiple sclerosis, myelination, oligodendrocyte differentiation, membrane remodeling, endocytosis
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alzheimer Disease, Female, Humans, Male, Middle Aged, Nuclear Proteins, Oligodendroglia, tau Proteins, Tumor Suppressor Proteins, Adaptor Proteins, Signal Transducing, Genome-Wide Association Study, Neurogenesis, White Matter
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts. https://app.cochat.ai/papers/10.1186/s13024-016-0124-1
- The paper
- De Rossi, P., Buggia-Prévot, V., Clayton, B. L. L., Vasquez, J. B., van Sanford, C., Andrew, R. J., Lesnick, R., Botté, A., Deyts, C., Salem, S., Rao, E., Rice, R. C., Parent, A., Kar, S., Popko, B., Pytel, P., Estus, S., & Thinakaran, G. (2016). Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts. Molecular Neurodegeneration. https://doi.org/10.1186/s13024-016-0124-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.